• Marylou Cardenas-Turanzas, Mark A Cesta, Chris Wakefield, Susannah Kish Wallace, Rudolph Puana, Kristen J Price, and Joseph L Nates.
• Department of Critical Care Medicine, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA. mcardena@mdanderson.org
• J Crit Care. 2010 Mar 1; 25 (1): 112-9.

PurposeThe study aimed to evaluate the relative impact of clinical and demographic factors associated with the prevalence and incidence of anemia (hemoglobin [Hb] <12 g/dL) in critically ill patients with cancer.Materials And MethodsWe performed an electronic chart review for demographic and clinical data of adult patients with cancer with or without anemia admitted to the intensive care unit (ICU). Prevalence of anemia was determined at admission, and incidence determined if anemia developed during ICU stay. Anemia was classified as mild, moderate, or severe. The additive impact of clinical and demographic factors was evaluated by using a hierarchical linear regression model.ResultsA total of 4705 patients were included in the study. The prevalence and incidence of anemia were 68.0% and 46.6%, respectively. In prevalent cases, we found that the clinical covariates modified sequential organ failure assessment score, admission to the medical ICU, prior chemotherapy, diagnosis of hematologic cancer, and length of hospital stay before ICU admission explained 18.7% of the variance in the model, whereas the demographic covariates (age, sex, and race) explained only an additional 0.6%. The pattern was similar for incidence cases.ConclusionsClinical factors are more influential than demographic factors in the observed rates of prevalence and incidence of anemia in the ICU; thus, protocols are needed to identify subgroups of patients with cancer who could benefit from novel management strategies.Copyright 2010 Elsevier Inc. All rights reserved.

29 keywords...

hide…